Clinical Trials Directory

Trials / Unknown

UnknownNCT04438421

Efficacy of Hyaluronic-acid and Hydrogen-Peroxide Mouthwash in Gingivitis Treatment

Efficacy of a Filming Formulation of Hydrogen Peroxide and Hyaluronic Acid (BMG0703) in the Treatment of Inflammation and Bleeding Caused by Gingivitis, Compared to Placebo and 0.2% Chlorhexidine. A Randomised Controlled Clinical Trial.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Milan · Academic / Other
Sex
All
Age
12 Years – 50 Years
Healthy volunteers
Not accepted

Summary

A clinical study to evaluate the efficacy and safety of a mouthwash containing Hydrogen Peroxide, Sodium Hyaluronate and Glycine in the prevention and management of complications associated gingivitis by film forming action.

Detailed description

50 subjects will be enrolled, who show with gingivitis caused by accumulation of plaque and/or tartar selected consecutively. Subsequently, subjects will be equally divided and randomized into the test group or control group. During the three examinations, the subjects will undergo the collection of bleeding and plaque indices according to Silness J \& Loe H 3,4. Four surfaces per tooth (vestibular, lingual/palatal, mesial, distal) will be considered.

Conditions

Interventions

TypeNameDescription
DRUGFilming mouthwash formulation, enriched with Hydrogen Peroxide and Hyaluronic AcidSubjects will then be given the test product, BMG0703, to be used twice a day after meals and after normal oral hygiene procedures. Next, the subjects will be re-evaluated after 3 days and after one month.
DRUGChlorhexidine mouthwashSubjects will then be given Chlorhexidine 0.2%mouthwash, as an active comparator, to be used twice a day after meals and after normal oral hygiene procedures. Next, the subjects will be re-evaluated after 3 days and after one month.
DRUGPlaceboSubjects will then be given a placebo product to be used twice a day after meals and after normal oral hygiene procedures. Next, the subjects will be re-evaluated after 3 days and after one month.

Timeline

Start date
2020-06-01
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2020-06-18
Last updated
2020-06-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04438421. Inclusion in this directory is not an endorsement.